JENNIFER DINOVO: Open Payments
NPI 1679127377 · NORTH PORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 40 payments from 14 companies in 2025. Trend: 2023 $1,149 · 2024 $983 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $155 |
| Novo Nordisk Inc | 5 | $98 |
| PFIZER INC. | 3 | $71 |
| Xeris Pharmaceuticals, Inc. | 3 | $67 |
| GlaxoSmithKline, LLC. | 4 | $59 |
| ABBVIE INC. | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Exact Sciences Corporation | 1 | $24 |
Products named: OTEZLA, ELIQUIS, RECORLEV, TRELEGY ELLIPTA, CAPLYTA, EVENITY, Ozempic, Rybelsus.
Industry payments across FL — which companies pay providers there.
